LSLF





 


FUNDED GRANTS 2000 - 2001

2001
David M. Loeb, MD, PhD
Division of Pediatric Oncology
Johns Hopkins University, Baltimore, MD

The Role of WTI in Resistant AMI
In Memory of Michael J. Lopez

Nicholas Mitsiades, MD
Dana Farber Cancer Institute, Boston, MA
Biotherapy of B-Cell Malignancies by Trial
Medicated Apoptosis

Grant made possible by the Johnny Mercer Foundation
In Memory of Johnny Mercer


Andromachi Scaradavou, MD
New York Blood Center Lindsay K. Kimball Research Institute Laboratory of Immunogenetics, New York, NY
Material Microchimerism in Unrelated Placental
Cord Blood Recipients

Grant made possible by Ford Motor Company

Jordan Fridman, PhD
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
Identification and Analysis of Drug Resistance
Mechanisms in Leukemia and Lymphoma

Grant made possible by The Ambassador Felix Schnyder Fund
In memory of Ambassador Felix Schnyder


Davorka Messmer, PhD
North Shore University Hospital,
Manhasset, NY

Generation of a CTL Response to B-CLL Cells
Using Tumor Antigen-Pulsed Dendritic Cells

Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder

2000
Dr. Raymond Comenzo, MD
Memorial Sloan-Kettering Cancer Center,
NY, NY

Study of the Use of Infusions of Stem Cells from Patients Following High-dose Chemotherapy or Radiation Therapy as an Alternative to Allogeneic Bone Marrow Transplant
In Memory of Louise Scheinberg

Erica Lerma, MD
Sidney Kimmel Cancer Center, San Diego, CA
Molecular Therapy of CML
In Memory of Michael J. Lopez

Jonathan Finlay, MB, ChB
New York University School of Medicine
Stephen D. Hassenfeld Center for Children’s Cancer and Blood Disorders
New York University Medical Center, NY, NY

Topotecan Phase I Clinical Trial for Leukemic,
Lymphomatous and Other Pediatric Neoplastic
Leptomeningeal Malignancies

In Honor of Adam Schwartz

Naoto Hirose, MD
North Shore University Hospital,
Manhasset, NY

Autoreactivity Maturation Stage in Gene
Expression in the Immunobiology and Clinical
Outcome of Chronic Lymphocytic Leukemia
Grant made possible by The Ambassador Felix Schnyder Fund

In memory of Ambassador Felix Schnyder

B. Hilda Ye, PhD
Albert Einstein College of Medicine
Cancer Center, Bronx, NY

Role of the BCL-6 Oncogene in Lymphoma
Cell Lines


Scott Lowe, PhD
Cold Spring Harbor Laboratory, Cold Spring Harbor,NY
Molecular Basis of Drug Resistance in a
Mouse Model of Leukemia and Lymphoma
Grant made possible by The Ambassador Felix Schnyder Fund

In memory of Ambassador Felix Schnyder

Nicholas Chiorazzi, MD and Charles C. Chu, PhD
North Shore University Hospital,
Manhasset, NY

Determination of Human Fig 1
Polymorphisms in SLE Patients
Grant made possible by The Muriel Fusfeld Foundaton

In memory of Muriel Fusfeld


1   2   3   4   5   6   7

LSLF

Lauri Strauss Leukemia Foundation
130 Shore Road • #114 • Port Washington, NY 11050
Telephone: 516-767-1415 • Fax: 516-767-9144 • Email:lslf@aol.com